Powered by

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

Jan 12, 2021 - GlobeNewswire
Board and Executive Moves

Dr. David Pyott, Director, Pliant Therapeutics Inc. Dr. Pyott joins the Pliant Board of Directors with more than 30 years of executive leadership and management experience within the global pharmaceutical industry. SOUTH SAN FRANCISCO, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the appointment of Dr. Dav...